Harout Dermendjian, MD
Vascular & Interventional Radiology · Valencia, CANPI 1689038424
Payments from drug & device makers
What this record shows
This record is dominated by other: $92,625 of the $102,243 with a category attached, or 90.6%. Angiodynamics, Inc. accounts for 93.9% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $71,512, more than ten times the $171 reported in 2020. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $612.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$96K
- Boston Scientific$800
- Medtronic$640
- Koya Medical, Inc.$500
- Globus Medical$488
- Abbott$482
- plus $3K from 31 others
What the payments were for
- Travel & lodging$1,9442%
- Food & beverage$7,5867%
- Education$880%
- Other$92,62591%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 37 | $96,021 |
| Boston Scientific | 14 | $800 |
| Medtronic(2 entities) | 9 | $640 |
| Koya Medical, Inc. | 1 | $500 |
| Globus Medical | 9 | $488 |
| Abbott | 23 | $482 |
| Inari Medical, Inc. | 5 | $428 |
| Stryker | 8 | $337 |
| Bard Peripheral Vascular, Inc. | 4 | $301 |
| Organogenesis Inc. | 8 | $181 |
| Veryan Medical Incorporated | 2 | $179 |
| Sanofi | 4 | $167 |
| Sirtex Medical Inc | 2 | $162 |
| Cagent Vascular Inc | 1 | $155 |
| Penumbra, Inc. | 1 | $139 |
| Mimedx Group, Inc. | 1 | $126 |
| Philips North America LLC | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Heartflow, Inc. | 5 | $106 |
| Irhythm Technologies, Inc. | 5 | $92 |
| Terumo Medical Corporation | 2 | $84 |
| Novartis | 4 | $71 |
| Abiomed | 2 | $60 |
| Kestra Medical Technology Services, Inc. | 2 | $56 |
| Nevro Corp. | 2 | $50 |
| Cleerly, Inc. | 2 | $47 |
| Johnson & Johnson(2 entities) | 2 | $45 |
| Revance Therapeutics, Inc. | 1 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $33 |
| Bayer | 1 | $32 |
| Edwards Lifesciences | 1 | $29 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Merck | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Shockwave Medical, Inc | 1 | $23 |
| Almirall LLC | 1 | $20 |
| Scpharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$92,874
- AngioVac$1,781
- Dayspring$1,500
- AlphaVac$713
- Koya Medical$500
- FLOWTRIEVER CATHETER, S$367
- CT THROMBECTOMY SYSTEM KIT$367
- INTELLIS ADAPTIVESTIM$345
- TheraSphere Y90 Glass Microspheres 10 GBq$273
- Venclose Maven Catheter$266
- Serrantor$155
- BioMimics 3D Vascular Stent System$151
- FlowTriever$150
- Indigo System$139
- AngioDynamics$136
- SIR-Spheres Microspheres$133
- Senza$127
- (5027) Intact Vascular Undivided$125
How this compares
$102,243 in reported general payments places this provider in the 90th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $8,202 |
| ClopidogrelClopidogrel Bisulfate | 25 | $155 |
| Gabapentin | 20 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $45 | $8,20212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 504 vascular & interventional radiology providers in California.
Other vascular & interventional radiology in Valencia
- Mahmood RazaviOrange$2.4M
- Keith TerasakiLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Edward LeeLos Angeles$1.4M
- Alexander MisonoNewport Beach$1.3M
- Kevin BurnsOrange$1.1M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
- Blaise BaxterSan Francisco$757K
- Navid EghbaliehLos Angeles$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.